Allogeneic transplantation outcomes amongst a contemporary cohort of high-risk myelodysplastic syndrome and acute myeloid leukemia patients aged ≥70 years

Allogeneic hematopoietic stem cell transplantation (HSCT) is an integral therapy for patients with hematological malignancies, myelodysplasia, and bone marrow failure. Its use has been increasing over the past decade, as understanding of the treatment and its related toxicities has led to changes in...

Description complète

Détails bibliographiques

Auteurs principaux:	Curtis Lachowiez, Rachel J. Cook, Brandon Hayes-Lattin, Richard T. Maziarz, Uma Borate, Elie Traer, Jessica Leonard, Laura Newell, Kim-Hien Dao, Gabrielle Meyers
Format:	Artigo
Langue:	Inglês
Publié:	Wolters Kluwer Medknow Publications 2019-01-01
Collection:	Hematology/Oncology and Stem Cell Therapy
Sujets:	acute myeloid leukemia allogeneic stem cell transplant bone marrow transplant flt-3 hypomethylating agent induction chemotherapy leukemia myelodysplastic syndrome targeted therapy
Accès en ligne:	https://journals.lww.com/10.1016/j.hemonc.2019.01.002
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!